The actions of Heidelberg Pharmas' corporate bodies are determined by the principles of good and responsible corporate governance. In this declaration, the Executive Management Board – also acting on behalf of the Supervisory Board – provides its report on corporate governance in the Group pursuant to section 289f of the German Commercial Code (HGB).
The Statement of Corporate Governance was adjusted with regard to the planned quota of women on the Executive Board and published in the amended version on 19 March 2024.